登录查看更多内容

VBL Targets Brain and other Cancers with Novel Immunotherapy

Daniel Levine

Principal at Levine Media Group

发布日期: 2017年9月14日

Glioblastoma is a devastating and fatal brain cancer that progresses rapidly. Median time from diagnosis to death is 12 to 15 months. In recurrent cases, treatment consists of both symptomatic and palliative therapies, but the disease remains fatal. VBL Therapeutics is developing a targeted anti-cancer gene-based therapy that is in late-stage testing for recurrent glioblastoma. We spoke to Dror Harats, CEO of VBL, about the therapy, how it works, and why it might be useful in treating a variety of cancers.

要查看或添加评论，请登录

Cell Therapies for Solid Tumors, Scaling N-of-1 Therapies, and Going Where Antibody Therapies Can't with AI

2024年11月1日
Damage Control, N-of-1 Therapies, and Introducing MitoCast

2024年10月1日
The Promise and Peril of CRISPR, Drug Developing Patients, and Going Deep with AI

2024年9月2日
The Next Blockbuster within You, Treatments for Nonsense, and Better Decision-Making through AI

2024年8月1日
AI, Real-World Data, and Regenerative Medicine

2024年7月1日
Immunotherapies, Genetic Medicines, and Patient Advocates Reinventing Drug Development

2024年6月3日
TIL Therapies, Transomics, and Questions of Value

2024年4月29日
Why a Topical Cannabidiol Gel May Help Treat the Behavioral Symptoms of Fragile X

2023年2月3日
A Company Where It takes Guts and Brains to Develop Drugs

2023年2月2日
An Ultra-Rare Disease Drug Developer Tries to Navigate Regulatory Uncertainty

2023年1月27日

查看全部

社区洞察

Data Mining

How can you ensure that your cancer diagnosis is accurate?
Patient Advocacy

How can you help patients understand cancer screening guidelines?
Artificial Intelligence

How can AI personalize cancer treatment plans?
Bioengineering

What are the limitations of molecular imaging in detecting early-stage cancer?
Case Management

What does a hematologist do?
Translational Research

How do you keep up with the latest advances and trends in biomarker translational research in oncology?
Consulting

What does a cancer information specialist do?
Bioengineering

How can image reconstruction techniques help doctors diagnose cancer more accurately?
Case Management

How do you create a cancer care provider network that meets the needs of patients?
Healthcare

What strategies can you use to address patient concerns during cancer education?

其他会员也浏览了

Cancer: A Battle Beyond Chemotherapy

Maliha Hafeez 1 年
PX-478, an HIF-1a inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer

xcellbio 8 个月
MMP-7 expression is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas

Connect2Clinic 4 个月
Effect of Bevacizumab administered prior to transarterial chemoembolization on the therapeutic effects of Lenvatinib in primary liver cancer patients

Connect2Clinic 1 年
【PLK1 Is Implicated in the Poor Prognosis of Hepatocellular Carcinoma】

Christine Xu 4 年
In Hodgkin Lymphoma survivors, it is not only radiotherapy that increases the risk of breast cancer – beware of doxorubicin.

Piotr J. Wysocki 8 个月
Seven minute cancer treatment jab

Natasha Spicer ?? Product Environmental Regulation Lead 1 年
Tumour-infiltrating lymphocyte cancer therapy nears FDA finish line

Peter Kirkpatrick 11 个月
Maintenance Chemotherapy Extends Life for Children With a Rare Cancer

Nicholas Focil 6 年
New analysis identifies patient populations with cancer-associated VTE who could benefit from treatment with oral, once-daily LIXIANA (edoxaban)

Emmanuele Kouvousis MD,MSc 6 年

Cell Therapies for Solid Tumors, Scaling N-of-1 Therapies, and Going Where Antibody Therapies Can't with AI

2024年11月1日

Damage Control, N-of-1 Therapies, and Introducing MitoCast

2024年10月1日

The Promise and Peril of CRISPR, Drug Developing Patients, and Going Deep with AI

2024年9月2日

The Next Blockbuster within You, Treatments for Nonsense, and Better Decision-Making through AI

2024年8月1日

AI, Real-World Data, and Regenerative Medicine

2024年7月1日

Immunotherapies, Genetic Medicines, and Patient Advocates Reinventing Drug Development

2024年6月3日

TIL Therapies, Transomics, and Questions of Value

2024年4月29日

Why a Topical Cannabidiol Gel May Help Treat the Behavioral Symptoms of Fragile X

2023年2月3日

A Company Where It takes Guts and Brains to Develop Drugs

2023年2月2日

An Ultra-Rare Disease Drug Developer Tries to Navigate Regulatory Uncertainty

2023年1月27日

社区洞察

其他会员也浏览了

Cancer: A Battle Beyond Chemotherapy

PX-478, an HIF-1a inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer

MMP-7 expression is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas

Effect of Bevacizumab administered prior to transarterial chemoembolization on the therapeutic effects of Lenvatinib in primary liver cancer patients

【PLK1 Is Implicated in the Poor Prognosis of Hepatocellular Carcinoma】

In Hodgkin Lymphoma survivors, it is not only radiotherapy that increases the risk of breast cancer – beware of doxorubicin.

Seven minute cancer treatment jab

Tumour-infiltrating lymphocyte cancer therapy nears FDA finish line

Maintenance Chemotherapy Extends Life for Children With a Rare Cancer

New analysis identifies patient populations with cancer-associated VTE who could benefit from treatment with oral, once-daily LIXIANA (edoxaban)